It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Dear UPC Prep Committee, please give us more time – and help to avoid a false start!
-
Changes to draft EU legislation introducing an export manufacturing waiver to SPCs
-
EPO: T 1410/14, Board of Appeal, 14 October 2015
-
Institut Pasteur v. Chiron: French patent law not hybridizable with the US “file wrapper estoppel” theory
-
Transfer of rights in patent application filed by party not entitled to do so – Higher Regional Court reluctantly follows Federal Court of Justice
-
UK FRAND Update
-
Antibodies, Biologics, Case Law, Damages, Infringement, Injunction, Litigation, United Kingdom, Validity
How do you solve a problem like… valid and infringed patents?
-
More time for discussion on Code of Conduct of Unified Patent Court
-
Barcelona Court of Appeal publishes most surprising Judgment on pharmaceutical patents, the role of the CJEU, and Art. 70.7 of TRIPS
-
New "PCT Direct" Service of the EPO – an opportunity for PCT applicants at the EPO to comment on objections raised by the EPO in an earlier search